| 3250 |
Performance Indicators and Targets for TB-HIV Collaborative Activities |
07/06/2024 |
TB Comorbidities and special conditions |
| 3251 |
TB-HIV joint review mechanisms |
07/06/2024 |
TB Comorbidities and special conditions |
| 3257 |
Treatment of DR-TB with HIV Coinfection |
07/06/2024 |
TB Comorbidities and special conditions |
| 3258 |
Treatment of DS-TB with HIV Coinfection |
07/06/2024 |
TB Comorbidities and special conditions |
| 3260 |
Isoniazid Preventive Therapy [IPT] in People Living with HIV [PLHIV] |
07/06/2024 |
TB Comorbidities and special conditions |
| 3262 |
Prevention of TB in facilities caring for HIV-infected persons |
07/06/2024 |
TB Comorbidities and special conditions |
| 3263 |
Reporting of ICF activities among PLHIV |
07/06/2024 |
TB Comorbidities and special conditions |
| 3279 |
F-ICTC |
07/06/2024 |
TB Comorbidities and special conditions |
| 3281 |
DR TB with HIV Co-infection |
07/06/2024 |
TB Comorbidities and special conditions |
| 4540 |
National Framework for A Gender-Responsive Approach to TB in India |
07/06/2024 |
TB Comorbidities and special conditions |
| 4726 |
TB-Diabetes service delivery integration |
07/06/2024 |
TB Comorbidities and special conditions |
| 4728 |
Reporting and recording for NPCDCS |
07/06/2024 |
TB Comorbidities and special conditions |
| 4730 |
Nutritional Requirements [Macro and Micro] in patients with Active TB |
07/06/2024 |
TB Comorbidities and special conditions |
| 4731 |
Nutritional Assessment |
07/06/2024 |
TB Comorbidities and special conditions |
| 4732 |
Pathway for Nutritional Management of patients with TB |
07/06/2024 |
TB Comorbidities and special conditions |
| 4861 |
Interventions for Screening of TB in TB-HIV Patients |
07/06/2024 |
TB Comorbidities and special conditions |
| 4862 |
Initiation of Anti-retroviral Therapy [ART] in PLHIV with DR-TB |
07/06/2024 |
TB Comorbidities and special conditions |
| 5692 |
Extra Pulmonary TB [EPTB] |
07/06/2024 |
TB Comorbidities and special conditions |
| 32 |
Infection Prevention and Control [IPC] |
07/06/2024 |
TB prevention including airborne infection control |
| 35 |
Reducing TB Vulnerabilities |
07/06/2024 |
TB prevention including airborne infection control |
| 55 |
Contact Tracing and Investigation |
07/06/2024 |
TB prevention including airborne infection control |
| 57 |
TB Infection |
07/06/2024 |
TB prevention including airborne infection control |
| 59 |
Vulnerable Population for Tuberculosis |
07/06/2024 |
TB prevention including airborne infection control |
| 73 |
Impact of COVID-19 on TB Elimination Efforts |
07/06/2024 |
TB prevention including airborne infection control |
| 74 |
Airborne Infection Control [AIC] |
07/06/2024 |
TB prevention including airborne infection control |
| 225 |
Ventilation as an AIC Measure |
07/06/2024 |
TB prevention including airborne infection control |
| 226 |
Administrative measures for AIC at a Health Facility |
07/06/2024 |
TB prevention including airborne infection control |
| 236 |
Roles of various stakeholders in IPC |
07/06/2024 |
TB prevention including airborne infection control |
| 253 |
Testing for TBI |
07/06/2024 |
TB prevention including airborne infection control |
| 255 |
Follow-up for TPT |
07/06/2024 |
TB prevention including airborne infection control |
